Hexaminolevulinate Hydrochloride Patent Expiration
Hexaminolevulinate Hydrochloride is Used for detection and diagnosis of bladder cancer using photodynamic cystoscopy. It was first introduced by Photocure Asa
Hexaminolevulinate Hydrochloride Patents
Given below is the list of patents protecting Hexaminolevulinate Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Cysview Kit | US11235168 | Method of photodynamic therapy (PDT) for bladder cancer | Jan 04, 2038 | Photocure Asa |
| Cysview Kit | US10556010 | Neoadjuvant therapy for bladder cancer | Dec 19, 2036 | Photocure Asa |
| Cysview Kit | US11311620 | Neoadjuvant therapy for bladder cancer | Dec 19, 2036 | Photocure Asa |
| Cysview Kit | US7348361 | Solution for diagnosing or treating tissue pathologies |
Apr 22, 2019
(Expired) | Photocure Asa |
| Cysview Kit | US7530461 | Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
Jan 11, 2017
(Expired) | Photocure Asa |
| Cysview Kit | US6034267 | Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
Mar 08, 2016
(Expired) | Photocure Asa |
| Cysview Kit | US7247655 | Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
Mar 08, 2016
(Expired) | Photocure Asa |
Hexaminolevulinate Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List